Artificial Intelligence meets Biological Systems

The problem we solve

We address the inefficiency of clinical trial success that is currently at 90% failure rate.

We have a biology focus whereas most companies in this space have a chemistry focus. This enables us to target an area of the clinical research and development that is currently underserved by the influx of computational modeling.